Fluorescence-guided Surgery and Fluorescence Laparoscopy for Gastrointestinal Cancers in Clinically-relevant Mouse Models

Overview

Journal Gastroenterol Res Pract

Publisher Wiley

Specialty Gastroenterology

Date 2013 Mar 28

PMID 23533387

Citations 11

Authors

Cristina A Metildi

Robert M Hoffman

Michael Bouvet

Affiliations

Soon will be listed here.

Abstract

There are many challenges that face surgeons when attempting curative resection for gastrointestinal cancers. The ability to properly delineate tumor margins for complete resection is of utmost importance in achieving cure and giving the patient the best chance of prolonged survival. Targeted tumor imaging techniques have gained significant interest in recent years to enable better identification of tumor lesions to improve diagnosis and treatment of cancer from preoperative staging modalities to optimizing the surgeon's ability to visualize tumor margins at the initial operation. Using unique characteristics of the tumor to fluorescently label the tissue can delineate tumor margins from normal surrounding tissue, allowing improved precision of surgical resection. In this paper, different methods of fluorescently labeling native tumor are discussed as well as the development of fluorescence laparoscopy and the potential role for fluorescence-guided surgery in the treatment of gastrointestinal cancers.

Citing Articles

Establishment of a guided, in vivo, multi-channel, abdominal, tissue imaging approach.

Bahlmann J, Madrahimov N, Daniel F, Theidel D, DeTemple D, Buettner M Sci Rep. 2020; 10(1):9224.

PMID: 32513950 PMC: 7280182. DOI: 10.1038/s41598-020-65950-w.

Effective fluorescence-guided surgery of liver metastasis using a fluorescent anti-CEA antibody.

Hiroshima Y, Lwin T, Murakami T, Mawy A, Kuniya T, Chishima T J Surg Oncol. 2016; 114(8):951-958.

PMID: 27696448 PMC: 5565879. DOI: 10.1002/jso.24462.

Color-coding cancer and stromal cells with genetic reporters in a patient-derived orthotopic xenograft (PDOX) model of pancreatic cancer enhances fluorescence-guided surgery.

Yano S, Hiroshima Y, Maawy A, Kishimoto H, Suetsugu A, Miwa S Cancer Gene Ther. 2015; 22(7):344-50.

PMID: 26088297 PMC: 4523223. DOI: 10.1038/cgt.2015.26.

Experimental Curative Fluorescence-guided Surgery of Highly Invasive Glioblastoma Multiforme Selectively Labeled With a Killer-reporter Adenovirus.

Yano S, Miwa S, Kishimoto H, Toneri M, Hiroshima Y, Yamamoto M Mol Ther. 2015; 23(7):1182-1188.

PMID: 25896244 PMC: 4817790. DOI: 10.1038/mt.2015.63.

Fluorescence-guided surgery improves outcome in an orthotopic osteosarcoma nude-mouse model.

Miwa S, Hiroshima Y, Yano S, Zhang Y, Matsumoto Y, Uehara F J Orthop Res. 2014; 32(12):1596-601.

PMID: 25138581 PMC: 4198468. DOI: 10.1002/jor.22706.

References

Stiles B, Adusumilli P, Bhargava A, Stanziale S, Kim T, Chan M . Minimally invasive localization of oncolytic herpes simplex viral therapy of metastatic pleural cancer. Cancer Gene Ther. 2005; 13(1):53-64. PMC: 1351128. DOI: 10.1038/sj.cgt.7700860. View

Bouvet M, Hoffman R . Glowing tumors make for better detection and resection. Sci Transl Med. 2011; 3(110):110fs10. DOI: 10.1126/scitranslmed.3003375. View

McElroy M, Kaushal S, Luiken G, Talamini M, Moossa A, Hoffman R . Imaging of primary and metastatic pancreatic cancer using a fluorophore-conjugated anti-CA19-9 antibody for surgical navigation. World J Surg. 2008; 32(6):1057-66. PMC: 4378829. DOI: 10.1007/s00268-007-9452-1. View

Kennedy M, Jallad K, Thompson D, Ben-Amotz D, Low P . Optical imaging of metastatic tumors using a folate-targeted fluorescent probe. J Biomed Opt. 2003; 8(4):636-41. DOI: 10.1117/1.1609453. View

Metildi C, Kaushal S, Hardamon C, Snyder C, Pu M, Messer K . Fluorescence-guided surgery allows for more complete resection of pancreatic cancer, resulting in longer disease-free survival compared with standard surgery in orthotopic mouse models. J Am Coll Surg. 2012; 215(1):126-35. PMC: 3383387. DOI: 10.1016/j.jamcollsurg.2012.02.021. View

Metildi C, Kaushal S, Snyder C, Hoffman R, Bouvet M . Fluorescence-guided surgery of human colon cancer increases complete resection resulting in cures in an orthotopic nude mouse model. J Surg Res. 2012; 179(1):87-93. PMC: 3518733. DOI: 10.1016/j.jss.2012.08.052. View

Kishimoto H, Kojima T, Watanabe Y, Kagawa S, Fujiwara T, Uno F . In vivo imaging of lymph node metastasis with telomerase-specific replication-selective adenovirus. Nat Med. 2006; 12(10):1213-9. DOI: 10.1038/nm1404. View

Kaushal S, McElroy M, Luiken G, Talamini M, Moossa A, Hoffman R . Fluorophore-conjugated anti-CEA antibody for the intraoperative imaging of pancreatic and colorectal cancer. J Gastrointest Surg. 2008; 12(11):1938-50. PMC: 4396596. DOI: 10.1007/s11605-008-0581-0. View

Bouvet M, Gamagami R, Gilpin E, Romeo O, Sasson A, Easter D . Factors influencing survival after resection for periampullary neoplasms. Am J Surg. 2000; 180(1):13-7. DOI: 10.1016/s0002-9610(00)00405-0. View

10.

Kishimoto H, Urata Y, Tanaka N, Fujiwara T, Hoffman R . Selective metastatic tumor labeling with green fluorescent protein and killing by systemic administration of telomerase-dependent adenoviruses. Mol Cancer Ther. 2009; 8(11):3001-8. PMC: 5529117. DOI: 10.1158/1535-7163.MCT-09-0556. View

11.

Kishimoto H, Aki R, Urata Y, Bouvet M, Momiyama M, Tanaka N . Tumor-selective, adenoviral-mediated GFP genetic labeling of human cancer in the live mouse reports future recurrence after resection. Cell Cycle. 2011; 10(16):2737-41. PMC: 3219541. DOI: 10.4161/cc.10.16.16756. View

12.

Nguyen Q, Olson E, Aguilera T, Jiang T, Scadeng M, Ellies L . Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival. Proc Natl Acad Sci U S A. 2010; 107(9):4317-22. PMC: 2840114. DOI: 10.1073/pnas.0910261107. View

13.

Yeo C, Cameron J, Lillemoe K, Sitzmann J, Hruban R, Goodman S . Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg. 1995; 221(6):721-31; discussion 731-3. PMC: 1234702. DOI: 10.1097/00000658-199506000-00011. View

14.

Stiles B, Bhargava A, Adusumilli P, Stanziale S, Kim T, Rusch V . The replication-competent oncolytic herpes simplex mutant virus NV1066 is effective in the treatment of esophageal cancer. Surgery. 2003; 134(2):357-64. DOI: 10.1067/msy.2003.244. View

15.

Metildi C, Kaushal S, Lee C, Hardamon C, Snyder C, Luiken G . An LED light source and novel fluorophore combinations improve fluorescence laparoscopic detection of metastatic pancreatic cancer in orthotopic mouse models. J Am Coll Surg. 2012; 214(6):997-1007.e2. PMC: 3360832. DOI: 10.1016/j.jamcollsurg.2012.02.009. View

16.

Kishimoto H, Zhao M, Hayashi K, Urata Y, Tanaka N, Fujiwara T . In vivo internal tumor illumination by telomerase-dependent adenoviral GFP for precise surgical navigation. Proc Natl Acad Sci U S A. 2009; 106(34):14514-7. PMC: 2732810. DOI: 10.1073/pnas.0906388106. View

17.

Tran Cao H, Kaushal S, Metildi C, Menen R, Lee C, Snyder C . Tumor-specific fluorescence antibody imaging enables accurate staging laparoscopy in an orthotopic model of pancreatic cancer. Hepatogastroenterology. 2012; 59(118):1994-9. PMC: 4096574. DOI: 10.5754/hge11836. View

18.

van Dam G, Themelis G, Crane L, Harlaar N, Pleijhuis R, Kelder W . Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results. Nat Med. 2011; 17(10):1315-9. DOI: 10.1038/nm.2472. View

19.

Olson E, Aguilera T, Jiang T, Ellies L, Nguyen Q, Wong E . In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer. Integr Biol (Camb). 2009; 1(5-6):382-93. PMC: 2796841. DOI: 10.1039/b904890a. View

20.

Jiang T, Olson E, Nguyen Q, Roy M, Jennings P, Tsien R . Tumor imaging by means of proteolytic activation of cell-penetrating peptides. Proc Natl Acad Sci U S A. 2004; 101(51):17867-72. PMC: 539314. DOI: 10.1073/pnas.0408191101. View